Navigation Links
The effects of smoking on fractures and ligament injuries

Cigarette smoking, which causes over 8.6 million illnesses annually in the U.S., has been shown to have harmful effects on a variety of orthopedic conditions. Studies have shown that the numerous toxins contained in cigarette smoke can undermine fracture and ligament repair following injury. In addition, smokers have higher rates of hip fracture, fracture healing problems and bone infections and smoking has been shown to impair soft tissue wound healing. Two new studies, funded by the National Institutes of Health and the National Football League Charities, examined the effects of smoking on fractures and ligament healing in mice and found that healing of both types of injury was delayed. The studies are published in the December 2006 issue of the Journal of Orthopaedic Research (, the official journal of the Orthopaedic Research Society.

Led by Hossam B. El-Zawawy of the Washington University School of Medicine in St. Louis, MO the first study involved 35 mice divided into a smoking group, which was exposed to cigarette smoke 6 days per week for a month, and a control group. Surgery was performed on all the mice to achieve a simple fracture. Researchers used type II collagen expression as a marker of cartilage formation (chondrogenesis) during healing. They found that smoking delayed fracture healing and that it began at the early stages of the healing process, although over time it did not inhibit normal healing. Specifically, they were able to show that there was a delay in the development of mature cartilage cells in the mice exposed to cigarette smoke. This was the first study to analyze the molecular and cellular mechanisms of fracture healing in mice exposed to smoke.

The authors note that while the study shows a clear relationship between smoking and cartilage formation, smoking probably has other effects on fracture healing, which shoul d be addressed in future studies. They conclude: "Clinically, if specific events can be identified, smoking cessation in humans, even temporarily, may improve or speed the healing process after injury and decrease the significant morbidity associated with cigarette smoking during fracture healing."

In the second study, involving the same group of researchers but led by Corey S. Gill, researchers examined the effects of smoking on medial collateral ligament (MCL) injury. They performed MCL surgery on 40 mice, half of which were exposed to cigarette smoke 6 days a week for two months. Researchers quantified cellular density at the site of injury and used Type I collagen gene expression as a marker for the formation of extracellular matrix, the material outside of cells that provides tissue support. The results showed for the first time that cellular density in mice increased between 3 and 7 days after injury in normal wound healing, and that this was partially inhibited in mice exposed to cigarette smoke. Based on their findings, the authors suggest that this delay is due to a difference in the recruitment of cells to the site of injury.

In addition, the study found that mice exposed to smoke had impaired or delayed extracellular matrix development, shown by lower collagen type I gene expression, one week after injury. This may lead to a delay in restoring biomechanical stability of the healing MCL. The authors conclude: "Ultimately, a better understanding of the cellular and molecular mechanisms involved in the MCL healing process will allow physicians to improve or speed the healing process, as well as potentially overcome the deleterious effects of smoking on ligament healing."


Source:John Wiley & Sons, Inc.

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Alcohols effects on gene expression in the central nervous system
3. Scientists discover how plants disarm the toxic effects of excessive sunlight
4. Physiological effects of reduced gravity on bacteria
5. Protein prevents detrimental immune effects of bacterial sepsis
6. The ecological effects of the Chernobyl disaster
7. Jefferson researchers find nanoparticle shows promise in reducing radiation side effects
8. Greasing interferons gears may pave way to greater therapeutic benefits, fewer side effects
9. Young scientists turn to gel to ease side-effects of cancer treatment
10. Losing sleep undoes the rejuvenating effects new learning has on the brain
11. Gene therapy protects mice from the effects of whole-body irradiation
Post Your Comments:

(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology: